As patients experience significant appetite suppression and reduced food intake, they may experience transient symptoms including fatigue, headache, and body discomfort
For example, semaglutide typically starts at a low dose (0.25 mg weekly) and increases to a maintenance dose (2.4 mg weekly for weight loss) over 16 to 20 weeks
To generate novel information about the functional pathways represented by these potential GLP-1R interactors, we performed pathway enrichment analysis with the GLP-1R binding partners exhibiting changes between vehicle and exendin-4-stimulated conditions using gProfiler
Zhao T, Parikh P, Bhashyam S, Bolukoglu H, Poornima I, Shen YT, Shannon RP: Direct effects of glucagon-like peptide-1 on myocardial contractility and glucose uptake in normal and postischemic isolated rat hearts
Our findings show that even when people feel some of those sensations returning, semaglutide continues to help them eat less